These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10523462)

  • 1. Hyperglycemia as a risk factor for cardiovascular disease in type 2 diabetes.
    Laakso M
    Prim Care; 1999 Dec; 26(4):829-39. PubMed ID: 10523462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglycemia and cardiovascular disease in type 2 diabetes.
    Laakso M
    Diabetes; 1999 May; 48(5):937-42. PubMed ID: 10331395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes.
    Haffner SM
    Diabetes Care; 1999 Apr; 22 Suppl 3():C54-6. PubMed ID: 10189563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
    Dailey G
    Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes.
    Colette C; Monnier L
    Horm Metab Res; 2007 Sep; 39(9):683-6. PubMed ID: 17846977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
    Sjöholm A
    Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperglycemia and cardiovascular disease.
    Duckworth WC
    Curr Atheroscler Rep; 2001 Sep; 3(5):383-91. PubMed ID: 11487449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?
    Haffner SM; Stern MP; Hazuda HP; Mitchell BD; Patterson JK
    JAMA; 1990 Jun; 263(21):2893-8. PubMed ID: 2338751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes.
    Smith-Palmer J; Brändle M; Trevisan R; Orsini Federici M; Liabat S; Valentine W
    Diabetes Res Clin Pract; 2014 Sep; 105(3):273-84. PubMed ID: 25023992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intensive glucose control in type 2 diabetes: is it harmful, needless or maybe useful in reducing cardiovascular risk?].
    Consoli A
    G Ital Cardiol (Rome); 2010 Dec; 11(12 Suppl 2):7S-11S. PubMed ID: 21361050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 diabetes and cardiovascular risk factors.
    Sharma MD; Farmer JA; Garber A
    Curr Med Res Opin; 2011 Nov; 27 Suppl 3():1-5. PubMed ID: 22106974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to ADVANCE prevention of cardiovascular complications in type 2 diabetes.
    Grobbee DE
    Metabolism; 2003 Aug; 52(8 Suppl 1):24-8. PubMed ID: 12939736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of glycemic control on the incidence of macrovascular complications of type 2 diabetes.
    Stern MP
    Arch Fam Med; 1998; 7(2):155-62. PubMed ID: 9519921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of blood glucose concentrations on the development of chronic complications of diabetes mellitus.
    Swidan SZ; Montgomery PA
    Pharmacotherapy; 1998; 18(5):961-72. PubMed ID: 9758308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of glycemic treatment choices on cardiovascular complications in type 2 diabetes.
    Weiss IA; Valiquette G; Schwarcz MD
    Cardiol Rev; 2009; 17(4):165-75. PubMed ID: 19525678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of postprandial hyperglycemia in the development of cardiovascular diseases in type 2 diabetes mellitus].
    Shvarts V
    Klin Med (Mosk); 2009; 87(11):17-24. PubMed ID: 20143560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysglycaemia, cardiovascular outcome and treatment. Is the jury still out?
    Bartnik M; Cosentino F
    Eur Heart J; 2009 Jun; 30(11):1301-4. PubMed ID: 19395498
    [No Abstract]   [Full Text] [Related]  

  • 18. Dysglycaemia and risk of cardiovascular disease.
    Jarrett RJ
    Lancet; 1996 Jun; 347(9018):1833-4. PubMed ID: 8667944
    [No Abstract]   [Full Text] [Related]  

  • 19. Implications of the United Kingdom prospective diabetes study.
    Baldeweg SE; Yudkin JS
    Prim Care; 1999 Dec; 26(4):809-27. PubMed ID: 10523461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
    Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal TP; Hemmingsen C; Wetterslev J
    Cochrane Database Syst Rev; 2013 Nov; (11):CD008143. PubMed ID: 24214280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.